BRAINSTORM CELL THERAPEUTICS INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.9M | $29.3M | $18.9M |
| FY2022 | $11.5M | $8.5M | $772.0K |
| FY2023 | $9.1M | $4.2M | $1.3M |
| FY2024 | $9.6M | $1.8M | $187.0K |
| FY2025 | $11.0M | $1.0M | $29.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $9.9M | $29.3M | $18.9M |
| FY2022 | $11.5M | $8.5M | $772.0K |
| FY2023 | $9.1M | $4.2M | $1.3M |
| FY2024 | $9.6M | $1.8M | $187.0K |
| FY2025 | $11.0M | $1.0M | $29.0K |